Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactnomycin and combination regimens (2008)
- Authors:
- USP affiliated authors: ANDRADE, JURANDYR MOREIRA DE - FMRP ; REIS, FRANCISCO JOSÉ CÂNDIDO DOS - FMRP ; TIÉZZI, DANIEL GUIMARÃES - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.ygyno.2007.09.006
- Subjects: GONADOTROFINA CORIÔNICA; QUIMIOTERAPIA; TROFOBLASTO; GRAVIDEZ
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Gynecologic Oncology
- ISSN: 0090-8258
- Volume/Número/Paginação/Ano: v. 108, n. 1, p. 149-153, 2008
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ABRÃO, Renato Antonio et al. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactnomycin and combination regimens. Gynecologic Oncology, v. 108, n. 1, p. 149-153, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ygyno.2007.09.006. Acesso em: 23 jul. 2024. -
APA
Abrão, R. A., Andrade, J. M. de, Tiezzi, D. G., Marana, H. R. C., Reis, F. J. C. dos, & Clagnan, W. S. (2008). Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactnomycin and combination regimens. Gynecologic Oncology, 108( 1), 149-153. doi:10.1016/j.ygyno.2007.09.006 -
NLM
Abrão RA, Andrade JM de, Tiezzi DG, Marana HRC, Reis FJC dos, Clagnan WS. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactnomycin and combination regimens [Internet]. Gynecologic Oncology. 2008 ; 108( 1): 149-153.[citado 2024 jul. 23 ] Available from: https://doi.org/10.1016/j.ygyno.2007.09.006 -
Vancouver
Abrão RA, Andrade JM de, Tiezzi DG, Marana HRC, Reis FJC dos, Clagnan WS. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactnomycin and combination regimens [Internet]. Gynecologic Oncology. 2008 ; 108( 1): 149-153.[citado 2024 jul. 23 ] Available from: https://doi.org/10.1016/j.ygyno.2007.09.006 - Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer
- Impact of surgical staging in locally advanced cervical cancer and subsequent chemotherapy
- Impacto prognóstico da recorrência local em pacientes com câncer inicial de mama submetidas a tratamento conservador
- Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium
- Expression of hypoxia-inducible factor 1-'alfa' and vascular endothelial growth factor-C in locally advanced breast cancer patients
- Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression
- Volume of breast tissue excised during breast-conserving surgery in patients undergoing preoperative systemic therapy
- Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
- Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response
- Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab
Informações sobre o DOI: 10.1016/j.ygyno.2007.09.006 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
